000 -LEADER |
fixed length control field |
03105pam a2200385 i 4500 |
001 - CONTROL NUMBER |
control field |
2022034219 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230824083853.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220909s2023 nyu b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2022034219 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781982171964 |
Qualifying information |
(hardcover) : |
Terms of availability |
$28.00 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
043 ## - GEOGRAPHIC AREA CODE |
Geographic area code |
n-us--- |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM172 |
Item number |
.M39 2023 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
362.17/840973 |
Edition number |
23 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
McLaughlin, Kathleen |
Titles and words associated with a name |
(Journalist), |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Blood money : |
Remainder of title |
the story of life, death, and profit inside America's blood industry / |
Statement of responsibility, etc. |
Kathleen McLaughlin. |
250 ## - EDITION STATEMENT |
Edition statement |
First One Signal Publishers/Atria Books hardcover edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
One Signal Publishers/Atria, |
Date of production, publication, distribution, manufacture, or copyright notice |
2023. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
227 pages ; |
Dimensions |
24 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references (pages 195-215) index. |
510 4# - CITATION/REFERENCES NOTE |
Name of source |
Kirkus Reviews, |
Location within source |
November 15, 2022 |
510 4# - CITATION/REFERENCES NOTE |
Name of source |
Publishers Weekly, |
Location within source |
December 12, 2022 |
510 4# - CITATION/REFERENCES NOTE |
Name of source |
Booklist, |
Location within source |
December 01, 2022 |
510 4# - CITATION/REFERENCES NOTE |
Name of source |
Kirkus Starred Reviews |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"Bad Blood meets Dreamland in this kaleidoscopic investigation into the shadowy and vampiric blood business and the dangerous limits of demand for the crucial resource that runs through our very veins. Every year, about twenty million Americans sell blood plasma for cash in a barely regulated market dominated by private industry and off-the-grid trafficking. These commercial efforts prey on an insatiable market for medical and scientific innovation fed from the veins of some of the country's most marginalized communities, such as undocumented immigrants and residents of poverty-stricken Flint, Michigan. We are often told that "blood donations" are used to save lives, but blood plasma, a component of whole blood, has become a precious commercial good. Blood plasma is collected and marketed by private industry, with the United States one of just five nations on the planet that have not yet banned the practice of pay-for-plasma giving. This precious resource is used for everything from expensive and unproven age-reversing treatments to costly and experimental cures for novel diseases like COVID-19. Based on a cross-country investigation into the plasma-giving capitals of the country, in-depth research into the blood industry, and her personal experience as a beneficiary of plasma-derived treatment for a rare condition, Kathleen McLaughlin's Blood Money reveals the underhanded machinations and unbalanced power structures of the blood industry. Taking us from China's blood black market to Silicon Valley's shadowy tech startups, this is an unforgettable inside look at an industry many of us had no idea even existed"-- |
Assigning source |
Provided by publisher. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Blood banks |
Geographic subdivision |
United States. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Blood products |
Geographic subdivision |
United States. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Poverty |
Geographic subdivision |
United States. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Online version: |
Main entry heading |
McLaughlin, Kathleen. |
Title |
Blood money |
Place, publisher, and date of publication |
New York : One Signal Publishers/Atria, 2023 |
International Standard Book Number |
9781982171988 |
Record control number |
(DLC) 2022034220 |